↓ Skip to main content

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer

Overview of attention for article published in BMC Cancer, March 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
Published in
BMC Cancer, March 2012
DOI 10.1186/1471-2407-12-83
Pubmed ID
Authors

Torben Frøstrup Hansen, Flemming Brandt Sørensen, Jan Lindebjerg, Anders Jakobsen

Abstract

MicroRNA-126 is the only microRNA (miRNA) known to be endothelial cell-specific influencing angiogenesis in several ways. The aim of the present study was to analyse the possible predictive value of miRNA-126 in relation to first line capecitabine and oxaliplatin (XELOX) in patients with metastatic colorectal cancer (mCRC).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 42 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 28%
Student > Ph. D. Student 12 28%
Student > Doctoral Student 5 12%
Student > Master 5 12%
Student > Bachelor 4 9%
Other 6 14%
Readers by discipline Count As %
Medicine and Dentistry 12 28%
Agricultural and Biological Sciences 11 26%
Biochemistry, Genetics and Molecular Biology 7 16%
Nursing and Health Professions 2 5%
Chemical Engineering 2 5%
Other 6 14%
Unknown 3 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2014.
All research outputs
#6,109,012
of 22,663,969 outputs
Outputs from BMC Cancer
#1,516
of 8,242 outputs
Outputs of similar age
#40,342
of 156,267 outputs
Outputs of similar age from BMC Cancer
#11
of 60 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 8,242 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,267 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.